Pheburane 483 mg/g, Granulat zur Herstellung einer Lösung zum Einnehmen

7680672630014 CH-67263 Granulat
Pheburane 483 mg/g, Granulat zur Herstellung einer Lösung zum Einnehmen
Pheburane 483 mg/g, Granulat zur Herstellung einer Lösung zum Einnehmen
Pheburane 483 mg/g, Granulat zur Herstellung einer Lösung zum Einnehmen
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Flasche(n)
Galenic form
Granulat
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/10/2024
Patient information leaflet
Français
16/10/2024
Patient information leaflet
Italien
16/10/2024
Summary of Product Characteristics
Allemand
16/10/2024
Summary of Product Characteristics
Français
16/10/2024
Summary of Product Characteristics
Italien
16/10/2024

Detailed composition

Substance Quantity Type Category
(N/A)
483.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
371.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
59.8 MG Substance HBESI

Reimbursement information

Public price
CHF 484.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2023

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
67263
Drug name
Pheburane, Granulat
Galenic form
GRAO
ATC Code
A16AX03
Authorization status
Z
Dispensing category
B
First authorization
29/07/2020
Authorization expiration date
31/12/9999
IT Number
07.99.0.
Domain
Human medicine
Field of application
Zusatztherapie bei der Langzeitbehandlung von Stoffwechselstörungen des Harnstoffzyklus

Package details

Description (FR)
PHEBURANE gran 483 mg/g fl 174 g
Description (DE)
PHEBURANE Gran 483 mg/g Fl 174 g
Market launch
29/07/2020
Narcotic (BTM)
No